BASF Considers Selling Parts of Biometric Subsidiary in Strategic Overhaul
By Aimee Look
BASF is mulling a sale of some of its biometric analysis subsidiary, trinamiX, as the German chemical group undergoes a broad restructuring.
The company said Monday it is looking at strategic options for subsidiary trinamiX, in an overhaul that aims to drive cost efficiencies and optimize value. The reassessment may include the sale of individual business areas and a change in management for trinamiX, BASF said.
TrinamiX's previous managing director, Ingmar Bruder, left the management board on Jan. 26, and will be replaced by Lothar Laupichler on Feb. 1, the company said. Laupichler previously ran BASF's global electronic materials business, the company added.
Mobile material analysis and biometric imaging company trinamiX was founded in 2015 as a BASF subsidiary, and has around 200 employees worldwide.
Meanwhile, BASF is undergoing a larger restructuring as it sells noncore assets, cuts jobs and spins off its agriculture business.
Write to Aimee Look at aimee.look@wsj.com
(END) Dow Jones Newswires
January 26, 2026 11:12 ET (16:12 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States